NMN vs nicotinamide riboside: form, purity and the label
NMN and nicotinamide riboside are different molecules: NMN carries a 5'-phosphate that NR does not. That phosphate changes the molecular weight, the salt form, the assay basis, the stability questions and the regulatory file. They are not interchangeable on a label or in a specification.
NMN and NR are one phosphate apart, and that phosphate changes the assay basis, the stability risks and the regulatory file.
Two molecules, one phosphate apart
| Property | NMN | Nicotinamide riboside |
|---|---|---|
| Chemical name | β-nicotinamide mononucleotide | Nicotinamide riboside |
| Formula | C11H15N2O8P | C11H14N2O5 |
| Molecular weight | 334.22 | 254.24 |
| Phosphate | 5'-phosphate present | None |
| Usual supplied form | Free acid, zwitterionic | Chloride salt |
NMN is the 5'-phosphorylated nucleoside; NR is the same nucleoside without the phosphate. The extra phosphate adds about 80 g/mol and makes NMN an acid. NMN is normally supplied as the free acid, which behaves as a zwitterion. NR is commonly supplied as the chloride salt. Those are different mass bases, not different names for the same powder.
What 98% means for each
Both ingredients are sold on a percentage, but the percentage is not the same measurement. An HPLC area percentage describes the share of the chromatographic peak area, not the mass of the named molecule in the drum. For NMN, the free acid has no counter-ion, so water and the α anomer are the main non-β components. For NR chloride, the chloride is part of the salt: about 87% of the salt's mass is NR, so a 98% HPLC figure is not 98% NR by mass.
The specification has to state the form and the basis. A certificate for NR chloride cannot be read as a certificate for NMN, and a certificate for NMN cannot be read as a certificate for NR. The two also have different related substances: NMN can hydrolyse to NR, so an NR peak in an NMN lot is a degradation or impurity signal, not a substitute ingredient.
A buyer comparing quotations should compare the form, the assay basis, the water and the anomer or salt content. The highest percentage is not the most informative line.
Stability questions are not the same
Both are water-soluble and hygroscopic, so the pack matters for both. NMN adds an ionisable phosphate and a 5% solution at pH 2.0–4.0. That acidity is a formulation fact: it can shift a low-buffer blend, and it sits beside hydrolysis and anomerisation as the first stability questions.
NR chloride brings its own salt and water uptake. The counter-ion, the water content and the pack have to be tested for the NR grade, not inferred from NMN data. A stability protocol for one molecule does not transfer to the other, even though the two are structurally close.
Compare stability data on the same basis: same pack, same temperature, same test points, same analytical method. A statement that one is more stable than the other needs that comparison; this page does not make it.
The regulatory files are separate
In the EU, the novel-food file for nicotinamide riboside chloride is separate from the file for NMN. Check the current entry for the form you buy, including its conditions of use and maximum daily amount.
In the US, the NMN position was revisited in 2025: the FDA's 2022 exclusion was reconsidered, and the agency stated that NMN is not excluded, reopening the NDI pathway. The US file for NR is separate and has to be checked on its own. A notification or a conclusion for one substance does not cover the other.
The UK register is separate again. The practical rule is simple: clear the molecule, the form and the market before the label is drafted. A supplier's statement about “NMN/NR” as a category is not a market-specific permission.
Naming the form on the label
The label must name the form. “NMN” alone does not say β; “NR” alone does not say chloride. The ingredient declaration, the assay basis and the net content have to match the specification. If the label says β-NMN and the drum contains a diluted or salt form, the label is wrong even if the HPLC number is high.
The two names are not synonyms on a label. A blend of NMN and NR is a third material, not a way to average the two. The label also has to carry the market's supplement particulars, the storage statement and the claim boundary; those are separate from the ingredient name.
Keep the COA, the specification and the artwork on the same form. A label change from NMN to NR is a new regulatory file, a new specification and a new stability pack, not a rename.
When to choose which
| Question | NMN | Nicotinamide riboside |
|---|---|---|
| Which form is named? | β-NMN, free acid | Nicotinamide riboside chloride |
| Which assay basis? | HPLC area; water and anomer | HPLC area; chloride salt |
| Which market file? | EU file: separate NR chloride entry; NMN checked separately | EU file: NR chloride entry; check US and UK |
| Which pack? | Hygroscopic, acidic powder | Hygroscopic salt |
Choose NMN when the destination market permits it, the label and specification call for β-NMN, and the analytical method can control the anomer. Choose NR when the market permits the NR form, the label calls for nicotinamide riboside chloride, and the salt basis is acceptable for the dose and the pack.
Choose neither on a claim. This page compares forms and files only. The decision belongs to the market permission, the label, the analytical control and the dosage form. If the market does not permit NMN, an NR file does not transfer. If the label says β-NMN, an NR blend is a different product.
The grade choices are on the NMN grade page; the regulatory position is on the compliance page; the identity tests are on the identity page. The catalog specification is on the NMN product page, and the lot-release process is set out on the quality page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation